CARGO Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Cash & Equivalents	406.3	1.87	0.04
Cash & Cash Equivalents	406.3	1.87	0.04
Cash Growth	21604.01%	4465.85%	-
Other Current Assets	3.18	2.06	0.14
Total Current Assets	409.48	3.93	0.18
Property, Plant & Equipment	38.6	5.53	3.88
Other Long-Term Assets	4.96	0.78	0.44
Total Long-Term Assets	43.56	6.32	4.32
Total Assets	453.04	10.24	4.5
Accounts Payable	5.01	3.48	0.82
Current Debt	2.28	22.91	0.94
Other Current Liabilities	13.87	17.74	0.69
Total Current Liabilities	21.16	44.14	2.45
Long-Term Debt	26.26	1.09	2.23
Other Long-Term Liabilities	0.23	0.25	0
Total Long-Term Liabilities	26.49	1.34	2.23
Total Liabilities	47.65	45.48	4.68
Total Debt	28.54	24	3.17
Debt Growth	18.90%	657.70%	-
Retained Earnings	-145.15	-47	-6.05
Shareholders' Equity	405.39	-35.24	-0.18
Net Cash / Debt	377.76	-22.13	-3.13
Net Cash Per Share	63.61	-56.42	-1.51
Working Capital	388.32	-40.21	-2.27
Book Value Per Share	68.26	-89.83	-0.09

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).